74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Sonova Holding AG
Open
SectorHealthcare
250.8 2.16
Overview
Share price change
24h
Min
245.2
Max
254.2
Income | 209M |
|---|---|
Sales | 1.8B |
P/E Sector Avg | 25.063 57.333 |
EPS | 3.5 |
Dividend yield | 1.81 |
Profit margin | 11.379 |
Employees | 18,554 |
EBITDA | 417M |
Recommendations | Sell |
|---|---|
12 Months Forecast | +5.38% upside |
Dividend yield Sector Avg | 1.81% 2.63% |
|---|---|
Next Earnings | 9 May 2025 |
Market Cap | -5B 14B |
|---|---|
Previous open | 248.64 |
Previous close | 250.8 |
Sonova Holding AG Chart
Past performance is not a reliable indicator of future results.
Related News
Sonova Holding AG Forecast
Price Target
By TipRanks
5.38% upside
12 Months Forecast
Average 254.7 CHF 5.38%
High 307 CHF
Low 182.178 CHF
Based on 6 Wall Street analysts offering 12 month price targets forSonova Holding AG - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Sonova Holding AG
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. The company was founded in 1947 and is headquartered in Stäfa, Switzerland.